Definitive Healthcare (NASDAQ:DH) Earns "Hold" Rating from Needham & Company LLC

Definitive Healthcare (NASDAQ:DH - Get Free Report)'s stock had its "hold" rating reaffirmed by stock analysts at Needham & Company LLC in a report released on Friday,Benzinga reports.

Several other research analysts have also weighed in on DH. Barclays dropped their price target on Definitive Healthcare from $6.00 to $4.00 and set an "equal weight" rating on the stock in a research report on Wednesday, August 7th. Robert W. Baird lowered their price objective on shares of Definitive Healthcare from $6.00 to $5.00 and set a "neutral" rating on the stock in a research report on Wednesday, August 7th. BTIG Research initiated coverage on shares of Definitive Healthcare in a research report on Tuesday, September 17th. They issued a "buy" rating and a $7.00 target price for the company. Deutsche Bank Aktiengesellschaft lowered their price target on shares of Definitive Healthcare from $7.00 to $5.00 and set a "hold" rating on the stock in a report on Friday, August 9th. Finally, Morgan Stanley cut their price objective on Definitive Healthcare from $9.00 to $5.00 and set an "equal weight" rating for the company in a report on Tuesday, August 6th. One analyst has rated the stock with a sell rating, seven have issued a hold rating and three have issued a buy rating to the company's stock. According to MarketBeat.com, the company has an average rating of "Hold" and an average target price of $5.81.

Definitive Healthcare Price Performance

Shares of NASDAQ:DH traded down $0.07 during trading hours on Friday, hitting $4.24. 1,200,343 shares of the company's stock traded hands, compared to its average volume of 750,774. The company's fifty day simple moving average is $4.37 and its two-hundred day simple moving average is $5.04. The company has a market cap of $500.04 million, a price-to-earnings ratio of -1.34, a price-to-earnings-growth ratio of 5.95 and a beta of 1.33. The company has a debt-to-equity ratio of 0.27, a quick ratio of 2.40 and a current ratio of 2.40. Definitive Healthcare has a 52 week low of $3.19 and a 52 week high of $10.62.

Definitive Healthcare (NASDAQ:DH - Get Free Report) last released its quarterly earnings data on Monday, August 5th. The company reported $0.09 earnings per share for the quarter, hitting the consensus estimate of $0.09. Definitive Healthcare had a positive return on equity of 0.98% and a negative net margin of 156.65%. The business had revenue of $63.70 million during the quarter, compared to analyst estimates of $63.19 million. During the same period last year, the company posted $0.08 EPS. The company's revenue was up 4.4% compared to the same quarter last year. As a group, equities analysts anticipate that Definitive Healthcare will post 0.07 EPS for the current fiscal year.

Hedge Funds Weigh In On Definitive Healthcare

Institutional investors have recently modified their holdings of the company. Victory Capital Management Inc. boosted its holdings in Definitive Healthcare by 6.5% in the 3rd quarter. Victory Capital Management Inc. now owns 542,170 shares of the company's stock valued at $2,424,000 after purchasing an additional 33,161 shares during the period. Hennion & Walsh Asset Management Inc. grew its position in Definitive Healthcare by 62.6% during the third quarter. Hennion & Walsh Asset Management Inc. now owns 37,940 shares of the company's stock worth $170,000 after buying an additional 14,609 shares in the last quarter. Bleakley Financial Group LLC bought a new position in Definitive Healthcare during the third quarter valued at about $74,000. SG Americas Securities LLC acquired a new position in Definitive Healthcare in the 3rd quarter valued at approximately $84,000. Finally, Sanctuary Advisors LLC bought a new stake in shares of Definitive Healthcare in the 2nd quarter worth approximately $85,000. Institutional investors own 98.67% of the company's stock.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.